307 related articles for article (PubMed ID: 33763072)
1. Agonistic Anti-CD40 Antibody Triggers an Acute Liver Crisis With Systemic Inflammation in Humanized Sickle Cell Disease Mice.
Yalamanoglu A; Dubach IL; Schulthess N; Ingoglia G; Swindle DC; Humar R; Schaer DJ; Buehler PW; Irwin DC; Vallelian F
Front Immunol; 2021; 12():627944. PubMed ID: 33763072
[TBL] [Abstract][Full Text] [Related]
2. The Red Blood Cell-Inflammation Vicious Circle in Sickle Cell Disease.
Nader E; Romana M; Connes P
Front Immunol; 2020; 11():454. PubMed ID: 32231672
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia/reoxygenation stress increases markers of vaso-occlusive crisis in sickle SAD mice.
Aufradet E; DeSouza G; Bourgeaux V; Bessaad A; Campion Y; Canet-Soulas E; Pialoux V; Chirico EN; Chevrier AM; Godfrin Y; Martin C
Clin Hemorheol Microcirc; 2013 Jan; 54(3):297-312. PubMed ID: 23696418
[TBL] [Abstract][Full Text] [Related]
4. A monocyte-TNF-endothelial activation axis in sickle transgenic mice: Therapeutic benefit from TNF blockade.
Solovey A; Somani A; Belcher JD; Milbauer L; Vincent L; Pawlinski R; Nath KA; Kelm RJ; Mackman N; O'Sullivan MG; Gupta K; Vercellotti GM; Hebbel RP
Am J Hematol; 2017 Nov; 92(11):1119-1130. PubMed ID: 28699284
[TBL] [Abstract][Full Text] [Related]
5. Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.
Vinchi F; Costa da Silva M; Ingoglia G; Petrillo S; Brinkman N; Zuercher A; Cerwenka A; Tolosano E; Muckenthaler MU
Blood; 2016 Jan; 127(4):473-86. PubMed ID: 26675351
[TBL] [Abstract][Full Text] [Related]
6. Chlorine inhalation induces acute chest syndrome in humanized sickle cell mouse model and ameliorated by postexposure hemopexin.
Alishlash AS; Sapkota M; Ahmad I; Maclin K; Ahmed NA; Molyvdas A; Doran S; Albert CJ; Aggarwal S; Ford DA; Ambalavanan N; Jilling T; Matalon S
Redox Biol; 2021 Aug; 44():102009. PubMed ID: 34044323
[TBL] [Abstract][Full Text] [Related]
7. Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease.
Belcher JD; Chen C; Nguyen J; Milbauer L; Abdulla F; Alayash AI; Smith A; Nath KA; Hebbel RP; Vercellotti GM
Blood; 2014 Jan; 123(3):377-90. PubMed ID: 24277079
[TBL] [Abstract][Full Text] [Related]
8. Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.
Belcher JD; Chen C; Nguyen J; Abdulla F; Zhang P; Nguyen H; Nguyen P; Killeen T; Miescher SM; Brinkman N; Nath KA; Steer CJ; Vercellotti GM
PLoS One; 2018; 13(4):e0196455. PubMed ID: 29694434
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of hepatic dysfunction in sickle cell disease: lessons from Townes mouse model.
Pradhan-Sundd T; Kato GJ; Novelli EM
Am J Physiol Cell Physiol; 2022 Aug; 323(2):C494-C504. PubMed ID: 35759437
[TBL] [Abstract][Full Text] [Related]
10. Vascular pathophysiology of sickle cell disease.
Connes P; Renoux C; Joly P; Nader E
Presse Med; 2023 Dec; 52(4):104202. PubMed ID: 37944640
[TBL] [Abstract][Full Text] [Related]
11. Original Research: Diametric effects of hypoxia on pathophysiology of sickle cell disease in a murine model.
Tan F; Ghosh S; Mosunjac M; Manci E; Ofori-Acquah SF
Exp Biol Med (Maywood); 2016 Apr; 241(7):766-71. PubMed ID: 27026725
[TBL] [Abstract][Full Text] [Related]
12. Oral carbon monoxide therapy in murine sickle cell disease: Beneficial effects on vaso-occlusion, inflammation and anemia.
Belcher JD; Gomperts E; Nguyen J; Chen C; Abdulla F; Kiser ZM; Gallo D; Levy H; Otterbein LE; Vercellotti GM
PLoS One; 2018; 13(10):e0205194. PubMed ID: 30308028
[TBL] [Abstract][Full Text] [Related]
13. MASP-2 and MASP-3 inhibitors block complement activation, inflammation, and microvascular stasis in a murine model of vaso-occlusion in sickle cell disease.
Belcher JD; Nguyen J; Chen C; Abdulla F; Conglin R; Ivy ZK; Cummings J; Dudler T; Vercellotti GM
Transl Res; 2022 Nov; 249():1-12. PubMed ID: 35878790
[TBL] [Abstract][Full Text] [Related]
14. MEK1/2 inhibitors reverse acute vascular occlusion in mouse models of sickle cell disease.
Zhao Y; Schwartz EA; Palmer GM; Zennadi R
FASEB J; 2016 Mar; 30(3):1171-86. PubMed ID: 26631480
[TBL] [Abstract][Full Text] [Related]
15. Control of Oxidative Stress and Inflammation in Sickle Cell Disease with the Nrf2 Activator Dimethyl Fumarate.
Belcher JD; Chen C; Nguyen J; Zhang P; Abdulla F; Nguyen P; Killeen T; Xu P; O'Sullivan G; Nath KA; Vercellotti GM
Antioxid Redox Signal; 2017 May; 26(14):748-762. PubMed ID: 26914345
[TBL] [Abstract][Full Text] [Related]
16. Cytokine profile of sickle cell disease in Oman.
Pathare A; Al Kindi S; Alnaqdy AA; Daar S; Knox-Macaulay H; Dennison D
Am J Hematol; 2004 Dec; 77(4):323-8. PubMed ID: 15551290
[TBL] [Abstract][Full Text] [Related]
17. Amelioration of inflammation and tissue damage in sickle cell model mice by Nrf2 activation.
Keleku-Lukwete N; Suzuki M; Otsuki A; Tsuchida K; Katayama S; Hayashi M; Naganuma E; Moriguchi T; Tanabe O; Engel JD; Imaizumi M; Yamamoto M
Proc Natl Acad Sci U S A; 2015 Sep; 112(39):12169-74. PubMed ID: 26371321
[TBL] [Abstract][Full Text] [Related]
18. Novel Sickle Cell Disease Therapies: Targeting Pathways Downstream of Sickling.
Morrone K; Mitchell WB; Manwani D
Semin Hematol; 2018 Apr; 55(2):68-75. PubMed ID: 30616808
[TBL] [Abstract][Full Text] [Related]
19. Acute hemolytic vascular inflammatory processes are prevented by nitric oxide replacement or a single dose of hydroxyurea.
Almeida CB; Souza LE; Leonardo FC; Costa FT; Werneck CC; Covas DT; Costa FF; Conran N
Blood; 2015 Aug; 126(6):711-20. PubMed ID: 26019278
[TBL] [Abstract][Full Text] [Related]
20. Acute Hemolysis and Heme Suppress Anti-CD40 Antibody-Induced Necro-Inflammatory Liver Disease.
Pfefferlé M; Ingoglia G; Schaer CA; Hansen K; Schulthess N; Humar R; Schaer DJ; Vallelian F
Front Immunol; 2021; 12():680855. PubMed ID: 34054870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
